Literature DB >> 203608

Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma.

M L Turbitt, R S Patrick, R B Goudie, W M Buchanan.   

Abstract

A retrospective examination in South-west Scotland of formalin-fixed paraffin-embedded liver tissue by an immunoperoxidase technique revealed hepatitis B surface antigen (HBsAg) in eight out of 81 cases (10%) of primary hepatocellular carcinoma (PHC) and in four out of 82 cases (5%) of cirrhosis. No positive staining was found in 112 controls without overt liver disease matched for age and sex. Unlike most previous studies showing an association between HBsAg and PHC, the present investigation was carried out in an area where HBs antigenaemia is infrequent and PHC is an uncommon tumour. While possibly hepatitis infection is an important cause of PHC, the association between HBsAg and PHC could be due merely to activation by the tumour of latent virus B in a previously infected person.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 203608      PMCID: PMC476694          DOI: 10.1136/jcp.30.12.1124

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

2.  Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

Authors:  M J Tong; S C Sun; B T Schaeffer; N K Chang; K J Lo; R L Peters
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

3.  Primary liver cancer, alpha1 fetoprotein and hepatitis B antigen in Papua New Guinea.

Authors:  D G Woodfield; Y Endo; T Matsuhashi
Journal:  Aust N Z J Med       Date:  1974-02

4.  Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

Authors:  W D Reed; R B Stern; A L Eddleston; R Williams; A J Zuckerman; A Bowes; P M Earl
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

5.  Australia antigen in Hong Kong Chinese.

Authors:  A K Lee
Journal:  Lancet       Date:  1972-05-20       Impact factor: 79.321

6.  Hepatitis-associated antigen and hepatoma in the U.S.

Authors:  E Alpert; K J Isselbacher
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

7.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum.

Authors:  S Sherlock; R A Fox; S P Niazi; P J Scheuer
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

8.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

9.  Background staining and sensitivity of the unlabelled antibody-enzyme (PAP) method. Comparison with the peroxidase labelled antibody sandwich method using formalin fixed paraffin embedded material.

Authors:  J Burns
Journal:  Histochemistry       Date:  1975-06-05

10.  A clinicopathological review of 100 cases of primary malignant tumours of the liver.

Authors:  R N MacSween
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

View more
  6 in total

1.  Link between hepatoma and hepatitis B.

Authors: 
Journal:  Br Med J       Date:  1978-09-09

2.  Detection of HBsAg containing cells in liver biopsies by different stains and classification of positively reacting ground-glass hepatocytes.

Authors:  F Borchard; V Gussmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-10

3.  Detection of hepatitis B surface antigen in fixed tissues of patients with cirrhosis and hepatoma.

Authors:  G Theodoropoulos; L Nakopoulou; M Repanti; N Papacharalampous; K Melissinos
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

4.  Hepatitis b infection in glomerulonephritis.

Authors:  J S O'Neill
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02

Review 5.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

6.  Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma.

Authors:  M C Kew; M B Ray; V J Desmet; J Desmyter
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.